← Back to headlines
Citius Pharmaceuticals Raises $36.5 Million for Lymphir Commercialization
Citius Pharmaceuticals has successfully raised $36.5 million in funding, which will be allocated towards the commercialization efforts for its drug Lymphir.
6 May, 13:04 — 6 May, 13:04
Sources
Showing 1 of 1 sources
